Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients

Clinical trial NCT07724873 · RECRUITING

Trial details

NCT number: NCT07724873
Sponsor: Tata Memorial Centre
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematopoietic Stem Cell Transplant (HSCT)GVHD - Graft-Versus-Host Disease Hematological Malignancy

Start date: 2025-01-28
Primary completion: 2029-12-03
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.